Integrating molecular medicine with functional proteomics: realities and expectations.

Area of Science:

• Proteomics
• Human disease research
• Therapeutic development

Background:

• The human proteome's availability necessitates advanced proteomic strategies for disease interpretation.
• Current methods range from high-quality, low-throughput studies to automated, transcriptomic-based diagnostics.

Purpose of the Study:

• To analyze proteomic challenges and technologies for functional disease understanding and therapeutic rectification.
• To evaluate the proximity of different proteomic approaches to revealing disease-initiation causality.

Main Methods:

• Contrast of low-throughput (e.g., 3-D reconstructions, transgenic studies) and high-throughput (e.g., transcriptomic analyses) data.
• Integration of data from model organism proteomic studies.
• Utilizing multi-compartment electrolyzers (MCE) and multi-photon detection (MPD) for human tissue profiling.

Main Results:

• High-quality, low-throughput methods offer deeper insights into disease phenotypes compared to automated diagnostics.
• Model organism data, particularly from Drosophila (genome-wide screens, gene interference, post-translational modifications), is crucial for understanding complex disease mechanisms.
• Advanced technologies like MCE and MPD are essential for detailed human proteomic profiling.

Conclusions:

• A combination of high-quality, targeted proteomic studies and integrated model organism data is vital for advancing human disease understanding.
• Cutting-edge technologies are key to overcoming current limitations in proteomic analysis for disease research.
• Prioritizing human embryogenesis, fetal development, and brain tissue is essential for relevant proteomic insights.